Načítá se...
Impact of regulatory changes on pharmacist-delivered telehealth during the COVID-19 pandemic
The 2020 coronavirus disease pandemic in the United States has created a dramatic need for the rapid implementation of telehealth services in areas of the country where telehealth is limited in scope. This implementation would not be possible without changes in how the Centers for Medicare and Medic...
Uloženo v:
| Vydáno v: | J Am Pharm Assoc (2003) |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Pharmacists Association®. Published by Elsevier Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7294253/ https://ncbi.nlm.nih.gov/pubmed/32593633 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.japh.2020.06.004 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|